Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review
Emilia Gatto, Victoria Aldinio
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
Rob M.A. de Bie, Carl E Clarke, Alberto J. Espay, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 5, pp. 452-461
Closed Access | Times Cited: 156
Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus
Ines Debove, Steffen Paschen, Deborah Amstutz, et al.
Movement Disorders (2024) Vol. 39, Iss. 2, pp. 235-248
Open Access | Times Cited: 21
Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
Gianpaolo Maggi, Francis Loayza, Carmine Vitale, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2798-2809
Open Access | Times Cited: 8
Sleep Issues in Parkinson's Disease and Their Management
José Rafael P. Zuzuárregui, Emmanuel During
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1480-1494
Open Access | Times Cited: 67
Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
Tamara Pringsheim, Gregory S. Day, Don B. Smith, et al.
Neurology (2021) Vol. 97, Iss. 20, pp. 942-957
Open Access | Times Cited: 53
The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders
C. Alejandra Morato Torres, Zinah Wassouf, Faria Zafar, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5724-5724
Open Access | Times Cited: 50
NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing Mice
Annadurai Anandhan, Nhat Nguyen, Arjun Syal, et al.
Aging and Disease (2021) Vol. 12, Iss. 4, pp. 964-964
Open Access | Times Cited: 45
Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
Stuart Isaacson, Robert A. Hauser, Rajesh Pahwa, et al.
Clinical Parkinsonism & Related Disorders (2023) Vol. 9, pp. 100212-100212
Open Access | Times Cited: 18
An opponent striatal circuit for distributional reinforcement learning
Adam S. Lowet, Zheng Qiao, Melissa Meng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Update on the Management of Parkinson’s Disease for General Neurologists
Zvezdan Pirtošek, Ovidiu Băjenaru, Norbert Kovács, et al.
Parkinson s Disease (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 49
The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson’s disease
T. Celeste Napier, Alana Kirby, Amanda L. Persons
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 102, pp. 109942-109942
Closed Access | Times Cited: 42
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study
Marie des Neiges Santin, Paul Voulleminot, Agathe Vrillon, et al.
Movement Disorders (2020) Vol. 36, Iss. 3, pp. 750-757
Closed Access | Times Cited: 42
The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine
Mattia Ferraiolo, Emmanuel Hermans
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108392-108392
Closed Access | Times Cited: 15
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients
Anna Maio, Tommaso Nuzzo, Luana Gilio, et al.
Neurobiology of Disease (2023) Vol. 184, pp. 106203-106203
Open Access | Times Cited: 14
Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease
Diego Santos‐García, Ariadna Laguna, Jorge Hernández‐Vara, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1329-1329
Open Access | Times Cited: 13
Sex differences in alpha-synucleinopathies: a systematic review
Kausar Raheel, Gemma Deegan, Irene Di Giulio, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 13
Uncovering the neurophysiology of mood, motivation and behavioral symptoms in Parkinson’s disease through intracranial recordings
Lucia Ricciardi, Matthew A J Apps, Simon Little
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Gambling Disorder in Parkinson’s Disease: A Scoping Review on the Challenge of Rehabilitation Strategies
Laura Culicetto, Federica Impellizzeri, Viviana Lo Buono, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 737-737
Open Access
Dopamine genetic risk scores and psychiatric symptoms: Interacting risk factors for impulse control behaviours in de novo Parkinson's disease
Emma Whooley, Vincent Koppelmans, Hayley J. MacDonald, et al.
Journal of Neuropsychology (2025)
Open Access
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?
Leonardo Rigon, Carmelo Fogliano, К. Ray Chaudhuri, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Impulse control and related behavioral disorders in Parkinson’s disease. Risk factors, diagnosis, and management. Is there a possible role for non-invasive brain stimulation?
Stefano Terruzzi, Lina Urh, Daniele Piscitelli, et al.
Neurological Sciences (2025)
Closed Access
Non-invasive Transcranial Electrical Stimulation in Movement Disorders
Jacky Ganguly, Aditya Murgai, Soumya Sharma, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 38
Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
Kathy Dujardin, Véronique Sgambato‐Faure
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 36
Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization
Héctor Hernández‐Parra, Hernán Cortés, José Arturo Ávalos‐Fuentes, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 19
Morphometric alterations of the mesocorticolimbic network in Parkinson’s disease with impulse control disorders
Mohammed Ansari, Shweta Prasad, Sujas Bhardwaj, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 229-237
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top